期刊文献+

阿司匹林与脑出血危险性的关系 被引量:25

Aspirin and risk of brain hemorrhage
下载PDF
导出
摘要 目的 研究国人服用阿司匹林与脑出血危险性的关系.方法 采用临床病例回顾分析方法,以1986年1月~2003年12月收住院TIA患者及腔隙性脑梗死患者为研究对象,分为服药组与未服药组,以出现新的脑梗死或脑出血;发生急性心肌梗死、TIA或死亡;中止服药或截至观察时间结束时为观察终点,观察脑出血的发生情况.结果 小剂量阿司匹林服药组(25~100mg/d)与对照组脑出血发生率之间无明显差别,P=0.316>0.05,RR=1.314,95%CI=0.771~2.242.中到大剂量阿司匹林服药组(300~900 mg/d)与对照组脑出血发生率之间有明显差别,P=0.000<0.05,RR=4.610,95%CI=2.198~9.670.小剂量阿司匹林组与中到大剂量阿司匹林组之间有明显差别,P=0.000<0.05,RR=3.602,95%CI=1.874~6.924.结论 TIA或腔隙性脑梗死患者服用小剂量阿司匹林进行2级预防不会增加脑出血的危险性,服用中等剂量到大剂量阿司匹林可以增加脑出血的危险性. Objective To study if Aspirin treatment in Asian people is associated with an increased risk of brain hemorrhage. Methods A retrospective study was applied. Subjects were the TIA and lacunar infarction paients of PUMC Hospital from January 1986 to December 2003. The patients were subgrouped as aspirin group and control group. The end point was a new stroke or brain hemorrhage,acute myocardial infarction,TIA or death ; terminal of drug or by time of the end of observation. The hemorrhagic events was observed. Results There was no significant difference between low-dose aspirin group and control group (P = 0. 316〉0.05, RR = 1. 314,95 %CI = 0. 771 -2. 242). There was significant difference between medium to high dose group and control group( p=0. 000 〈 0. 05, RR = 4.610,95 %CI = 2.198 - 9. 670). There was significant difference between low-dose group and medium to high dose group(P=0.000〈0.05,RR=3.602,95% CI=1.874-6.924).Conclusions Low-dose Aspirn therapy does not increase the risk of hemorrhagic stroke. However ,medium to high dose Aspirin therapy increases the risk.
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2007年第2期196-198,共3页 Journal of Apoplexy and Nervous Diseases
关键词 脑梗死 脑出血 阿司匹林 二级预防 Stroke Brain hemorrhage Aspirin Secondary prevention
  • 相关文献

参考文献15

  • 1Rantanen K,Tatlisumak T.Secondary prevention of ischemic stroke[J].Current Drug Targets,2004,5:457-472.
  • 2Wu GX,Wu ZS,He BL.Epidemiological characteristics of stroke in 16 provinces of China[J].Chin Med J,1994,74:281-283.
  • 3Harrison M,Marshall J,Meadows J,et al.Effect of Aspirin in amaurosis fugax[J].Lancet,1971,2(7727):743-744.
  • 4朱佩华,杨菊华,李东辉,姚万青.阿司匹林对脑梗死患者血清C反应蛋白影响及抗血小板聚集作用的临床观察[J].中风与神经疾病杂志,2006,23(5). 被引量:7
  • 5Bousser MG,Haguenau EM,Lefaucconnier JM,et al."AICLA"Controlled trial of Aspirin and Dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia[J].Stroke,1983,14(1):5-14.
  • 6Per SS,Holger P,Jorgen M,et al.Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks.A Danish cooperative study[J].Stroke,1983,14 (1):15-22.
  • 7Annette LG,Birgitte GK,Palle P.Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation[J].Arch Intern Med,1999,159:1322-1328.
  • 8Risk factors for stroke and efficacy of antithrombotic therapy inatrial fibrillation.Analysis of pooled data from five randomized controlled trials[J].Arch Intern Med,1994,154:1449-1457.
  • 9A Swedish Cooperative Study.High-dose acetylaslicylic acid after cerebral infarction[J].Stroke,1987,18 (2):325-334.
  • 10Culebras A,Rotta ER,Dominguez R,et al.Triflusal vs aspirin for prevention of cerebral infarction.A randomized stroke study[J].Neurology,2004,62:1073-1080.

二级参考文献7

同被引文献214

引证文献25

二级引证文献111

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部